Metronomic and metronomic-like therapies in neuroendocrine tumors – rationale and clinical perspectives

An anti-tumor therapy characterized by high efficacy alongside with low adverse events and low costs would be ideal. Maybe the answer is not in a certain drug, but in a certain way of maneuvering the oncological treatment, taking into account Fidler and Ellis’ statement that: “Cancer is a chronic disease and should be treated like other chronic diseases“ [1].

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lwQoib
via IFTTT